301 related articles for article (PubMed ID: 26824576)
21. Fraternal twins with Phelan-McDermid syndrome not involving the SHANK3 gene: case report and literature review.
Li S; Xi KW; Liu T; Zhang Y; Zhang M; Zeng LD; Li J
BMC Med Genomics; 2020 Oct; 13(1):146. PubMed ID: 33023580
[TBL] [Abstract][Full Text] [Related]
22. Characterisation of the clinical phenotype in Phelan-McDermid syndrome.
Burdeus-Olavarrieta M; San José-Cáceres A; García-Alcón A; González-Peñas J; Hernández-Jusdado P; Parellada-Redondo M
J Neurodev Disord; 2021 Jul; 13(1):26. PubMed ID: 34246244
[TBL] [Abstract][Full Text] [Related]
23. Functional genomics analysis of Phelan-McDermid syndrome 22q13 region during human neurodevelopment.
Ziats CA; Grosvenor LP; Sarasua SM; Thurm AE; Swedo SE; Mahfouz A; Rennert OM; Ziats MN
PLoS One; 2019; 14(3):e0213921. PubMed ID: 30875393
[TBL] [Abstract][Full Text] [Related]
24. Clinical, genetic, and cognitive correlates of seizure occurrences in Phelan-McDermid syndrome.
Levy T; Gluckman J; Siper PM; Halpern D; Zweifach J; Filip-Dhima R; Holder JL; Trelles MP; Johnson K; Bernstein JA; Berry-Kravis E; Powell CM; Soorya LV; Thurm A; Buxbaum JD; Sahin M; Kolevzon A; Srivastava S;
J Neurodev Disord; 2024 May; 16(1):25. PubMed ID: 38730350
[TBL] [Abstract][Full Text] [Related]
25. Phelan-McDermid syndrome: clinical report of a 70-year-old woman.
Verhoeven WM; Egger JI; Cohen-Snuijf R; Kant SG; de Leeuw N
Am J Med Genet A; 2013 Jan; 161A(1):158-61. PubMed ID: 23166010
[TBL] [Abstract][Full Text] [Related]
26. The Neurological Manifestations of Phelan-McDermid Syndrome.
Frank Y
Pediatr Neurol; 2021 Sep; 122():59-64. PubMed ID: 34325981
[TBL] [Abstract][Full Text] [Related]
27. Phelan-McDermid Syndrome and SHANK3: Implications for Treatment.
Costales JL; Kolevzon A
Neurotherapeutics; 2015 Jul; 12(3):620-30. PubMed ID: 25894671
[TBL] [Abstract][Full Text] [Related]
28. 22q13.2q13.32 genomic regions associated with severity of speech delay, developmental delay, and physical features in Phelan-McDermid syndrome.
Sarasua SM; Dwivedi A; Boccuto L; Chen CF; Sharp JL; Rollins JD; Collins JS; Rogers RC; Phelan K; DuPont BR
Genet Med; 2014 Apr; 16(4):318-28. PubMed ID: 24136618
[TBL] [Abstract][Full Text] [Related]
29. Phelan-McDermid syndrome in two adult brothers: atypical bipolar disorder as its psychopathological phenotype?
Verhoeven WM; Egger JI; Willemsen MH; de Leijer GJ; Kleefstra T
Neuropsychiatr Dis Treat; 2012; 8():175-9. PubMed ID: 22570549
[TBL] [Abstract][Full Text] [Related]
30. Lithium as a rescue therapy for regression and catatonia features in two SHANK3 patients with autism spectrum disorder: case reports.
Serret S; Thümmler S; Dor E; Vesperini S; Santos A; Askenazy F
BMC Psychiatry; 2015 May; 15():107. PubMed ID: 25947967
[TBL] [Abstract][Full Text] [Related]
31. Cerebellar and posterior fossa malformations in patients with autism-associated chromosome 22q13 terminal deletion.
Aldinger KA; Kogan J; Kimonis V; Fernandez B; Horn D; Klopocki E; Chung B; Toutain A; Weksberg R; Millen KJ; Barkovich AJ; Dobyns WB
Am J Med Genet A; 2013 Jan; 161A(1):131-6. PubMed ID: 23225497
[TBL] [Abstract][Full Text] [Related]
32. Genotype-phenotype correlation in Phelan-McDermid syndrome: A comprehensive review of chromosome 22q13 deleted genes.
Ricciardello A; Tomaiuolo P; Persico AM
Am J Med Genet A; 2021 Jul; 185(7):2211-2233. PubMed ID: 33949759
[TBL] [Abstract][Full Text] [Related]
33. [Advance of research on Phelan-McDermid syndrome].
Li S; Xi K; Liu T; Zhang Y; Li J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Sep; 38(9):917-920. PubMed ID: 34487544
[TBL] [Abstract][Full Text] [Related]
34. A translocation between Xq21.33 and 22q13.33 causes an intragenic SHANK3 deletion in a woman with Phelan-McDermid syndrome and hypergonadotropic hypogonadism.
Misceo D; Rødningen OK; Barøy T; Sorte H; Mellembakken JR; Strømme P; Fannemel M; Frengen E
Am J Med Genet A; 2011 Feb; 155A(2):403-8. PubMed ID: 21271662
[TBL] [Abstract][Full Text] [Related]
35. Phelan-McDermid syndrome: a classification system after 30 years of experience.
Phelan K; Boccuto L; Powell CM; Boeckers TM; van Ravenswaaij-Arts C; Rogers RC; Sala C; Verpelli C; Thurm A; Bennett WE; Winrow CJ; Garrison SR; Toro R; Bourgeron T
Orphanet J Rare Dis; 2022 Jan; 17(1):27. PubMed ID: 35093143
[TBL] [Abstract][Full Text] [Related]
36. A previously unrecognized 22q13.2 microdeletion syndrome that encompasses TCF20 and TNFRSF13C.
Upadia J; Gonzales PR; Atkinson TP; Schroeder HW; Robin NH; Rudy NL; Mikhail FM
Am J Med Genet A; 2018 Dec; 176(12):2791-2797. PubMed ID: 30216695
[TBL] [Abstract][Full Text] [Related]
37. Framework for assessing individuals with rare genetic disorders associated with profound intellectual and multiple disabilities (PIMD): the example of Phelan McDermid Syndrome.
Soorya L; Leon J; Trelles MP; Thurm A
Clin Neuropsychol; 2018; 32(7):1226-1255. PubMed ID: 29265961
[TBL] [Abstract][Full Text] [Related]
38. [The Phelan-McDermid syndrome (22q13 microdeletion) - case report].
Slezak R; Laczmańska I
Med Wieku Rozwoj; 2011; 15(1):96-100. PubMed ID: 21786519
[TBL] [Abstract][Full Text] [Related]
39. Parental perspectives on Phelan-McDermid syndrome: Results of a worldwide survey.
Landlust AM; Koza SA; Carbin M; Walinga M; Robert S; Cooke J; Vyshka K; ; van Balkom IDC; van Ravenswaaij-Arts C
Eur J Med Genet; 2023 Jul; 66(7):104771. PubMed ID: 37120079
[TBL] [Abstract][Full Text] [Related]
40. Evidence for common mechanisms of pathology between SHANK3 and other genes of Phelan-McDermid syndrome.
Mitz AR; Boccuto L; Thurm A
Clin Genet; 2024 May; 105(5):459-469. PubMed ID: 38414139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
